Has Angela Chapman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $39,779 in general payments to Angela Chapman, MD across 126 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Angela Chapman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Angela Chapman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Angela Chapman, MD

Psychiatry · Fayetteville, ARNPI 1639197973

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $37,160 of the $39,779 with a category attached, or 93.4%. AbbVie accounts for 98.1% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $23,913 and has fallen 99.0% since, to $238 in 2025. Among psychiatry clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$39,779in general payments, 2019–2025

Across 126 payments — averaging $315.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$39K
Takeda Pharmaceuticals U.S.A., Inc.$271
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$211
Corium, LLC$92
Lundbeck LLC$46
Ironshore Pharmaceuticals Inc.$38
plus $98 from 4 others

What the payments were for

Speaking & faculty fees$37,16093%
Travel & lodging$1,5794%
Food & beverage$1,0333%
Education$70%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	54	$39,021
Takeda Pharmaceuticals U.S.A., Inc.	24	$271
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	29	$211
Corium, LLC	8	$92
Lundbeck LLC	3	$46
Ironshore Pharmaceuticals Inc.	2	$38
Sunovion Pharmaceuticals Inc.	3	$37
Vanda Pharmaceuticals Inc.	1	$35
Shire North American Group Inc	1	$14
Neuronetics, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VRAYLAR$38,472

How this compares

$39,779 in reported general payments places this provider in the 95th percentile of 235 psychiatry providers in Arkansas.

See all psychiatry providers in Arkansas →

Medicare billing

Part B allowed, 2024

$12,912

Medicare patients

Services billed

152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RexultiBrexpiprazole	13	$18,769
Lisdexamfetamine Dimesylate	13	$3,372
Aripiprazole	50	$1,789
Imipramine Pamoate	12	$1,746
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate	11	$1,730
Venlafaxine Hcl ErVenlafaxine Hcl	111	$1,335
Bupropion XlBupropion Hcl	81	$1,297
Lamotrigine	142	$1,273
Quetiapine Fumarate	107	$1,241
Clonazepam	298	$1,205
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	41	$1,012
Duloxetine Hcl	76	$1,012
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	43	$857
Alprazolam	82	$805
Imipramine Hcl	11	$776

Paid to pharmacies, not to this prescriber.

Other psychiatry in Fayetteville

Jacquelyn Lange-HalleyFayetteville$8K
Devin McDonaldFayetteville$6K
Shefa RahmanFayetteville$4K
Robert BillingsleyFayetteville$2K
Leslie SmithLittle Rock$766K
Tad TillemansLittle Rock$656K
Steven KoryElm Springs$628K
Ronald WautersSearcy$204K
Herman ClementsSearcy$187K
Randal ScholmaLowell$111K

See the full list for Arkansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →